E Bravo-Esteban1, J Taylor2, J Abián-Vicén3, S Albu2, C Simón-Martínez2, D Torricelli4, J Gómez-Soriano5. 1. Sensorimotor Function Group, Hospital Nacional de Parapléjicos, Toledo, Spain IAI, Consejo Superior de Investigación Cientifíca (CSIC), Arganda del Rey, Spain. 2. Sensorimotor Function Group, Hospital Nacional de Parapléjicos, Toledo, Spain. 3. Department of Physical Therapy, Universidad Camilo José Cela, Madrid, Spain. 4. IAI, Consejo Superior de Investigación Cientifíca (CSIC), Arganda del Rey, Spain. 5. Sensorimotor Function Group, Hospital Nacional de Parapléjicos, Toledo, Spain Escuela de Enfermería y Fisioterapia, Universidad de Castilla LaMancha, Toledo, Spain.
Abstract
BACKGROUND: Although the spasticity syndrome is an important sensorimotor disorder, the impact of grade of lower limb muscle hypertonia, spasm and clonus activity on voluntary muscle function, gait and daily activities has not been systematically analysed during subacute and chronic spinal cord injury (SCI). OBJECTIVE: To determine the prevalence of spasticity signs and symptoms during SCI, and to assess their impact on motor function and activities. METHODS: A descriptive transverse study of sixty-six subjects with SCI was performed by assessing injury characteristics, spasticity (modified Ashworth scale, Penn scale, SCATS scale) and motor function (lower limb manual muscle scores, WISCI II, spinal cord injury spasticity evaluation tool). RESULTS: Most subjects with the spasticity syndrome presented lower limb hypertonia and spasms during both subacute and chronic SCI, interfering with daily life activities. Subjects with incomplete SCI and hypertonia revealed a loss of voluntary flexor muscle activity, while extensors spasms contributed strongly to loss of gait function. The Penn spasms scale no correlated with muscle function or gait. CONCLUSIONS: Specific diagnosis of spasm activity during subacute SCI, and its impact on lower limb voluntary muscle activity, gait function and daily activities, is required to develop a more effective neurorehabilitation treatment strategy.
BACKGROUND: Although the spasticity syndrome is an important sensorimotor disorder, the impact of grade of lower limb muscle hypertonia, spasm and clonus activity on voluntary muscle function, gait and daily activities has not been systematically analysed during subacute and chronic spinal cord injury (SCI). OBJECTIVE: To determine the prevalence of spasticity signs and symptoms during SCI, and to assess their impact on motor function and activities. METHODS: A descriptive transverse study of sixty-six subjects with SCI was performed by assessing injury characteristics, spasticity (modified Ashworth scale, Penn scale, SCATS scale) and motor function (lower limb manual muscle scores, WISCI II, spinal cord injury spasticity evaluation tool). RESULTS: Most subjects with the spasticity syndrome presented lower limb hypertonia and spasms during both subacute and chronic SCI, interfering with daily life activities. Subjects with incomplete SCI and hypertonia revealed a loss of voluntary flexor muscle activity, while extensors spasms contributed strongly to loss of gait function. The Penn spasms scale no correlated with muscle function or gait. CONCLUSIONS: Specific diagnosis of spasm activity during subacute SCI, and its impact on lower limb voluntary muscle activity, gait function and daily activities, is required to develop a more effective neurorehabilitation treatment strategy.
Authors: Frederico Ribeiro Neto; Rodrigo R Gomes Costa; Jefferson R Dorneles; Carlos W Gonçalves; João H C L Veloso; Rodrigo L Carregaro Journal: Top Spinal Cord Inj Rehabil Date: 2021-08-13
Authors: Jacqueline Tibbett; Eva G Widerström-Noga; Christine K Thomas; Edelle C Field-Fote Journal: J Spinal Cord Med Date: 2018-01-15 Impact factor: 1.985
Authors: Denise M Peters; Yann Thibaudier; Joan E Deffeyes; Gila T Baer; Heather B Hayes; Randy D Trumbower Journal: J Neurotrauma Date: 2017-10-27 Impact factor: 5.269
Authors: Jose A Corleto; Mariana Bravo-Hernández; Kota Kamizato; Osamu Kakinohana; Camila Santucci; Michael R Navarro; Oleksandr Platoshyn; Dasa Cizkova; Nadezda Lukacova; Julian Taylor; Martin Marsala Journal: PLoS One Date: 2015-12-29 Impact factor: 3.240
Authors: Elisabeth Bravo-Esteban; Julian Taylor; Manuel Aleixandre; Cristina Simon-Martínez; Diego Torricelli; José L Pons; Julio Gómez-Soriano Journal: J Neuroeng Rehabil Date: 2014-03-04 Impact factor: 4.262
Authors: Filipe O Barroso; Diego Torricelli; Elisabeth Bravo-Esteban; Julian Taylor; Julio Gómez-Soriano; Cristina Santos; Juan C Moreno; José L Pons Journal: Front Hum Neurosci Date: 2016-01-11 Impact factor: 3.169